Intrinsic Value of S&P & Nasdaq Contact Us

Schrödinger, Inc. SDGR NASDAQ

NASDAQ Global Select • Healthcare • Medical - Healthcare Information Services • US • USD

SharesGrow Score
59/100
3/7 Pass
SharesGrow Intrinsic Value
$155.32
+1204.1%
Analyst Price Target
$18.00
+51.1%
SharesGrow 7-Criteria Score All 7 criteria scored · valuation-related highlighted on this page

Schrödinger, Inc. (SDGR) has a negative trailing P/E of -8.2, meaning the company is currently unprofitable on a trailing twelve-month (TTM) basis. The forward P/E of 91.6 based on analyst estimates suggests a return to profitability is expected. Trailing earnings yield is -12.21%, forward earnings yield 1.09%. PEG 0.26 (Peter Lynch undervalued ≤1.0).

Criteria proven by this page:

  • VALUE (100/100, Pass) — PEG ≤ 1.0 — Peter Lynch undervalued (0.26); analyst target implies upside (+51.1%).
  • Forward P/E 91.6 — analysts expect a return to profitability with estimated EPS of $0.13 for FY2029.
  • PEG Ratio 0.26 — below 1.0 suggests the stock is undervalued relative to its earnings growth rate (Peter Lynch criterion).
  • Trailing Earnings Yield -12.21% — negative yield confirms the company is currently unprofitable. Investors are paying for a turnaround rather than current earnings. Forward yield improves to 1.09% as earnings recover.
  • Analyst consensus target $18.00 (+51.1% upside) — significant upside potential according to Wall Street analysts.

Overall SharesGrow Score: 59/100 with 3/7 criteria passed.

SharesGrow 7-Criteria Score
59/100
SG Score
View full scorecard →
VALUE
100/100
Price-to-Earnings & upside
Proven by this page
FUTURE
73/100
Analyst consensus
→ Forecast
PAST
25/100
→ Income
HEALTH
100/100
Debt-to-Equity & liquidity
→ Health
~
MOAT
60/100
→ Income
~
GROWTH
48/100
→ Income
INCOME
10/100
→ Income

Valuation Snapshot — SDGR

Valuation Multiples
P/E (TTM)-8.2
Forward P/E91.6
PEG Ratio0.26
Forward PEG0.26
P/B Ratio2.32
P/S Ratio3.32
EV/EBITDA-8.5
Per Share Data
EPS (TTM)$-1.41
Forward EPS (Est.)$0.13
Book Value / Share$4.96
Revenue / Share$3.48
FCF / Share$0.17
Yields & Fair Value
Earnings Yield-12.21%
Forward Earnings Yield1.09%
Dividend Yield0.00%
SharesGrow IV$155.32 (+1204.1%)
Analyst Target$18.00 (+51.1%)

Historical Valuation

Year P/E (TTM) PEG Ratio P/B Ratio P/S Ratio Dividend Yield
2017 -9.3 0.00 -3.58 2.92 -
2018 -48.8 0.60 -19.40 20.83 -
2019 -73.7 2.42 -19.41 21.18 -
2020 -194.3 -26.55 7.62 43.97 -
2021 -24.5 -0.11 4.41 17.83 -
2022 -8.9 -0.19 2.97 7.35 -
2023 63.1 -0.50 4.68 11.86 -
2024 -7.5 0.01 3.33 6.75 -
2025 -12.7 0.28 3.61 5.13 -

EPS: Actual vs Estimates

P/E Ratio & Earnings Yield

Earnings Per Share (EPS) History

Year EPS (Diluted) Revenue Net Income Net Margin
2017 $-0.43 $55.69M $-17.39M -31.2%
2018 $-0.59 $66.64M $-28.43M -42.7%
2019 $-0.41 $85.54M $-25.68M -30%
2020 $-0.44 $108.1M $-26.64M -24.6%
2021 $-1.43 $137.93M $-101.22M -73.4%
2022 $-2.10 $180.96M $-149.19M -82.4%
2023 $0.54 $216.67M $40.72M 18.8%
2024 $-2.57 $207.54M $-187.12M -90.2%
2025 $-1.41 $255.87M $-103.27M -40.4%

Analyst Estimates

Year EPS (Avg) EPS Range Revenue (Avg) Revenue Range Analysts
2026 $-2.12 $-3.27 – $0.12 $253.87M $211.4M – $325.63M 4
2027 $-1.48 $-1.96 – $-0.80 $262.12M $244.88M – $275M 3
2028 $-0.39 $-1.66 – $1.02 $334.9M $326.59M – $343.21M 3
2029 $0.13 $0.11 – $0.16 $385.96M $346.14M – $459.72M 1
2030 $0.58 $0.50 – $0.72 $431.19M $386.7M – $513.59M 1
Contact Us
🎓
SharesGrow Academy
Learn how to calculate Intrinsic Value and find undervalued stocks.
Weekly live sessions
Send us a message